Mihael H. Polymeropoulos

2018

In 2018, Mihael H. Polymeropoulos earned a total compensation of $4.3M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 13% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$700,000
Option Awards$1,610,154
Salary$700,000
Stock Awards$1,237,200
Other$37,322
Total$4,284,676

Polymeropoulos received $1.6M in option awards, accounting for 38% of the total pay in 2018.

Polymeropoulos also received $700K in non-equity incentive plan, $700K in salary, $1.2M in stock awards and $37.3K in other compensation.

Rankings

In 2018, Mihael H. Polymeropoulos' compensation ranked 2,539th out of 14,244 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 82.2% of executives.

ClassificationRankingPercentile
All
2,539
out of 14,244
82nd
Division
Manufacturing
934
out of 5,762
84th
Major group
Chemicals And Allied Products
319
out of 2,125
85th
Industry group
Drugs
259
out of 1,814
86th
Industry
Pharmaceutical Preparations
202
out of 1,388
85th
Source: SEC filing on April 25, 2019.

Polymeropoulos' colleagues

We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2018.

2018

Timothy Williams

Vanda Pharmaceuticals

General Counsel

2018

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2018

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2018

Gunther Birznieks

Vanda Pharmaceuticals

Senior Vice President, Business Development

News

You may also like